Theracell Laboratories is a leading biotechnology company based in Greece. Established in 2013, it specializes in the development of innovative cellular and gene therapy products and is involved in the commercialization of a diverse pipeline of Cell and Gene Therapy (CGT) products. The company’s therapeutic portfolio spans the areas of Orthopedics, Dermatology, Nephrology, Immuno-Oncology, and Tissue Repair and Regeneration.
Theracell Laboratories participates in the global vision of the realization of Personalized Medicine tailored to individual patient needs. The main goal fo the company is the expansion of the therapeutic pipeline, with novel cell and gene therapy products developed using tailored processes to meet patients’ needs.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 27 Evrota, Kifisiá,attiki 145 64,greece
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://theracell.eu/
- HQ
- Kifisiá, Attiki
Theracell Questions
Theracell's website is https://theracell.eu/
Theracell's LinkedIn profile is https://gr.linkedin.com/company/theracellgr
Theracell has
14 employees.
View email and phone details for 14
employees at Theracell.
Theracell's industry is
Biotechnology Research
Theracell's top competitors are
Eurogenetica,
Iasis Pharmaceuticals Hellas S.a.,
Idna Genomics,
Omnigen Biotechnological Applications S.a.,
Genepharm Sa,
Genekor Medical S.a.,
Idna Laboratories,
Phenotypos,
Qualia Pharma S.a.,
Orgenesis Inc..
Theracell's categories are Biotechnology Research
Theracell's founding year is 2013
